Fairness opinions › Acquirers
Aetna: healthcare acquisitions with fairness opinions
2 public-company targets, 2012-2017, $98B combined enterprise value. The multiples Aetna paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
8.1x
Median EV / revenue paid
0.55x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2017-12-03 | CVS Health | Aetna | Pharmacy / Infusion | $90B | 7.2x | 0.49x | 7.0%–8.5% | Allen, Barclays, Goldman Sachs, Centerview Partners |
| 2012-08-20 | Coventry Health Care | Aetna | Managed Care | $8.7B | 8.9x | 0.61x | 7.5%–9.5% | Greenhill |